Molecular Imaging Identifies Link between Heart and Kidney Inflammation after Heart Attack

July 12, 2020

Reston, VA—Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction, or heart attack. According to research presented at the Society of Nuclear Medicine and Molecular Imaging’s 2020 Annual Meeting, the identification of a systemic inflammatory response to myocardial infarction has the potential to assist physicians in identifying patients most at risk of disease progression and most likely to respond to therapy.

Patients with acute myocardial infarction often develop impaired kidney function, thought to be mediated by the activation and mobilization of immune cells, or inflammation. While inflammation is necessary for effective healing, uncontrolled inflammatory cell activity can be detrimental for both the heart and the kidneys. To further understand the mechanics of this bidirectional interaction, researchers conducted a preclinical analysis of a novel imaging agent that targets inflammatory cells after myocardial infarction.

Using serial whole-body CXCR4-targeted 68Ga-pentixafor PET, researchers imaged 65 mice after surgically-induced myocardial infarction or sham surgery at one day, three days, seven days and six weeks. Tracer retention was determined in the kidneys and compared to infarct signal and cardiac function, as measured independently by magnetic resonance.

Cardiac CXCR4 signal was significantly elevated on the first day of imaging and returned to sham level after seven days. Renal CXCR4 signal was unchanged on the first day of imaging, but was reduced after seven days as compared to sham levels. Cardiac and renal signal were directly correlated, suggesting an inflammatory link between the heart and the kidneys. Ex-vivo autoradiography confirmed a significant correlation between tracer retention in the myocardial infarction region and the kidneys.

“This study provides a foundation for simultaneous examination of heart and kidneys after myocardial infarction by using molecular imaging,” noted Rudolf Werner, MD, PhD, resident in the department of nuclear medicine at Hannover Medical School in Hannover, Germany. “It provides an impetus for the pursuit of systems-based multi-organ imaging to investigate systemic response to focal injury.”

He continued, “Assessment of inflammation after myocardial infarction is beginning to be evaluated in clinical populations. With the growth of long-bore cameras with larger fields of view, the concept of multi-organ imaging will expand substantially in the next years.

In the future, nuclear medicine techniques may identify the optimal patient and time point for anti-inflammatory therapy, and identify the added risk to off-target organs after primary injury.”

Abstract 28. “Imaging inflammation crosstalk along the cardio-renal axis after acute myocardial infarction,” Rudolf Werner, Annika Hess, Tobias Ross, James Thackeray and Frank Bengel, Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany, Technische Universitaet Muenchen, Garching, Germany, Department of Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Hannover Germany, and Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; Hans Wester, Technische Universitaet Muenchen, Garching, Germany; and Anette Melk, Department of Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Hannover, Germany. SNMMI’s 67th Annual Meeting, July 11-14, 2020.  

This work was supported by the German Research Foundation (DFG), through the PRACTIS – Clinical Scientist Program of Hannover Medical School (ME 3696/3-1).

Link to Abstract

###

All 2020 SNMMI Annual Meeting abstracts can be found online at http://jnm.snmjournals.org/content/61/supplement_1.toc.

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.